The emergence of T790M mutation in EGFR-mutant lung adenocarcinoma patients having a history of acquired resistance to EGFR-TKI: focus on rebiopsy timing and long-term existence of T790M

פריטים דומים

• Mutational monitoring of EGFR T790M in cfDNA for clinical outcome prediction in EGFR-mutant lung adenocarcinoma
  מאת: Su, Kang-Yi, et al.
  יצא לאור: (2018)
• An Observational Study of Acquired EGFR T790M-Dependent Resistance to EGFR-TKI Treatment in Lung Adenocarcinoma Patients in Taiwan
  מאת: Wu, Shang-Gin, et al.
  יצא לאור: (2020)
• The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M
  מאת: Huang, Yen-Hsiang, et al.
  יצא לאור: (2021)
• T790M and acquired resistance of EGFR TKI: a literature review of clinical reports
  מאת: Ma, Chunyan, et al.
  יצא לאור: (2011)
• Primary Tumor Radiotherapy During EGFR-TKI Disease Control Improves Survival of Treatment Naïve Advanced EGFR-Mutant Lung Adenocarcinoma Patients
  מאת: Hsu, Kuo-Hsuan, et al.
  יצא לאור: (2021)